LIG1 Loss Reveals Targetable Weakness Against Chemotherapy-Resistant Triple-Negative Breast Cancer
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
In a new study published in Cell Death Discovery, researchers report that piceatannol—a natural polyphenol—may act as a “senotherapeutic,” helping ...
In a groundbreaking study poised to reshape our understanding of autoimmune diseases, researchers have unveiled a previously unrecognized mechanism by ...
The quest for precise prognostic biomarkers in cancer has led researchers to explore the multifaceted roles of the Rho GTPase-activating ...
In a monumental leap forward for genetics and cancer research, scientists at the Spanish National Cancer Research Centre (CNIO) have ...
In the ever-evolving landscape of cellular biology and cancer research, few proteins have garnered as much attention and intrigue as ...
Recent groundbreaking research conducted by scientists at UMass Chan Medical School has yielded promising insights into the mechanisms underlying the ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine